| Date | Time | Source | Headline | Symbol | Company |
| 05/26/2009 | 12:50PM | Business Wire | Eastbourne Calls on All Amylin Shareholders to Vote Today and Support Change to the Amylin Board of Directors | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2009 | 11:04AM | Edgar (US Regulatory) | Proxy Statement - Non-Management (definitive, revised) (DFRN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/22/2009 | 3:16PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/22/2009 | 11:45AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/22/2009 | 10:50AM | Business Wire | Eastbourne Calls on Amylin Employees to Help Shape the Company’s Future and Support Change to the Board | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/21/2009 | 3:02PM | Dow Jones News | Hedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin Slate | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/21/2009 | 12:01PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 5:10PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 4:18PM | Business Wire | Fourth Independent Proxy Advisory Firm Recommends Change to Board of Directors at Amylin Pharmaceuticals | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 3:55PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 1:53PM | PR Newswire (US) | Amylin Responds to Eastbourne Letter | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 11:46AM | Business Wire | Eastbourne Sends Letter to Amylin Board | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 10:20AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2009 | 9:27AM | PR Newswire (US) | Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/19/2009 | 5:02PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2009 | 4:39PM | Business Wire | Eastbourne Capital Sends Letter to Amylin Shareholders Outlining Broad Call for Change to Amylin Board | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2009 | 10:56AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2009 | 10:11AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2009 | 9:02AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2009 | 8:17AM | Dow Jones News | More Proxy Advisers Back Dissidents' Amylin Board Nominees | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/18/2009 | 7:00AM | Business Wire | Three Leading Independent Proxy Advisory Firms Now Support Change at Amylin Pharmaceuticals | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2009 | 6:06AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/15/2009 | 7:53PM | PR Newswire (US) | Amylin Comments on RiskMetrics Report | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/15/2009 | 7:02PM | Business Wire | RiskMetrics Supports Change to the Board of Directors at Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/15/2009 | 6:24PM | Dow Jones News | UPDATE: Risk Metrics Backs Three Dissident Amylin Directors | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/15/2009 | 5:53PM | Dow Jones News | Risk Metrics Backs Three Dissident Directors For Amylin Board | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/15/2009 | 6:01AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2009 | 5:18PM | Business Wire | Amylin’s Statements Are Unsubstantiated and Conclusory Says Eastbourne | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2009 | 12:28PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2009 | 11:13AM | Dow Jones News | UPDATE: Icahn Fires Back At Amylin Over Latest Letter | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |